High-dimensional quantum key distribution based on mutually partially unbiased bases

We propose a practical high-dimensional quantum key distribution protocol based on mutually partially unbiased bases utilizing transverse modes of light. In contrast to conventional protocols using mutually unbiased bases, our protocol uses Laguerre-Gaussian and Hermite-Gaussian modes of the same mode order as two mutually partially unbiased bases for encoding, which leads to a scheme free from mode-dependent diffraction in long-distance channels. Since only linear and passive optical elements are needed, our experimental implementation significantly simplifies qudit generation and state measurement. Since this protocol differs from conventional protocols using mutually unbiased bases, we provide a security analysis of our protocol

Light-induced dynamic frequency shifting of microwave photons in a superconducting electro-optic converter

Hybrid superconducting-photonic microresonators are a promising platform for realizing microwave-to-optical transduction. However, the absorption of scattered photons by the superconductors leads to unintended microwave resonance frequency variation and linewidth broadening. Here, we experimentally study the dynamics of this effect and its impact on microwave-to-optics conversion in an integrated lithium niobate-superconductor hybrid resonator platform. We unveiled an adiabatic frequency shifting of the intracavity microwave photons induced by the fast photo-responses of the thin-film superconducting resonator. As a result, the temporal and spectral responses of electro-optics transduction are modified and well described by our theoretical model. This work provides important insights on the light-induced conversion dynamics which must be considered in future designs of hybrid superconducting-photonic system

Photonic link from single flux quantum circuits to room temperature

Broadband, energy-efficient signal transfer between cryogenic and room-temperature environment has been a major bottleneck for superconducting quantum and classical logic circuits. Photonic links promise to overcome this challenge by offering simultaneous high bandwidth and low thermal load. However, the development of cryogenic electro-optic modulators -- a key component for photonic readout of electrical signals -- has been stifled by the stringent requirements of superconducting circuits. Rapid single flux quantum circuits (RSFQ), for example, operate with a tiny signal amplitude of only a few millivolts (mV), far below the volt-level signal used in conventional circuits. Here, we demonstrate the first direct optical readout of an RSFQ circuit without additional electrical amplification enabled by a novel superconducting electro-optic modulator (SEOM) featuring a record-low half-wave voltage V{\pi} of 42 mV on a 1 m-long SEOM. Leveraging the low ohmic loss of superconductors, we break the fundamental V{\pi}-bandwidth trade-off and demonstrate electro-optic bandwidth up to 17 GHz on a 0.2 m-long SEOM at cryogenic temperatures. Our work presents a viable solution toward high-bandwidth signal transfer between future large-scale superconducting circuits and room-temperature electronics

Shifting from Population-wide to Personalized Cancer Prognosis with Microarrays

The era of personalized medicine for cancer therapeutics has taken an important step forward in making accurate prognoses for individual patients with the adoption of high-throughput microarray technology. However, microarray technology in cancer diagnosis or prognosis has been primarily used for the statistical evaluation of patient populations, and thus excludes inter-individual variability and patient-specific predictions. Here we propose a metric called clinical confidence that serves as a measure of prognostic reliability to facilitate the shift from population-wide to personalized cancer prognosis using microarray-based predictive models. The performance of sample-based models predicted with different clinical confidences was evaluated and compared systematically using three large clinical datasets studying the following cancers: breast cancer, multiple myeloma, and neuroblastoma. Survival curves for patients, with different confidences, were also delineated. The results show that the clinical confidence metric separates patients with different prediction accuracies and survival times. Samples with high clinical confidence were likely to have accurate prognoses from predictive models. Moreover, patients with high clinical confidence would be expected to live for a notably longer or shorter time if their prognosis was good or grim based on the models, respectively. We conclude that clinical confidence could serve as a beneficial metric for personalized cancer prognosis prediction utilizing microarrays. Ascribing a confidence level to prognosis with the clinical confidence metric provides the clinician an objective, personalized basis for decisions, such as choosing the severity of the treatment

A convolutional neural network-based auto-segmentation pipeline for breast cancer imaging

Medical imaging is crucial for the detection and diagnosis of breast cancer. Artificial intelligence and computer vision have rapidly become popular in medical image analyses thanks to technological advancements. To improve the effectiveness and efficiency of medical diagnosis and treatment, significant efforts have been made in the literature on medical image processing, segmentation, volumetric analysis, and prediction. This paper is interested in the development of a prediction pipeline for breast cancer studies based on 3D computed tomography (CT) scans. Several algorithms were designed and integrated to classify the suitability of the CT slices. The selected slices from patients were then further processed in the pipeline. This was followed by data generalization and volume segmentation to reduce the computation complexity. The selected input data were fed into a 3D U-Net architecture in the pipeline for analysis and volumetric predictions of cancer tumors. Three types of U-Net models were designed and compared. The experimental results show that Model 1 of U-Net obtained the highest accuracy at 91.44% with the highest memory usage; Model 2 had the lowest memory usage with the lowest accuracy at 85.18%; and Model 3 achieved a balanced performance in accuracy and memory usage, which is a more suitable configuration for the developed pipeline

HEROHE Challenge: Predicting HER2 Status in Breast Cancer from Hematoxylin–Eosin Whole-Slide Imaging

Breast cancer is the most common malignancy in women worldwide, and is responsible for more than half a million deaths each year. The appropriate therapy depends on the evaluation of the expression of various biomarkers, such as the human epidermal growth factor receptor 2 (HER2) transmembrane protein, through specialized techniques, such as immunohistochemistry or in situ hybridization. In this work, we present the HER2 on hematoxylin and eosin (HEROHE) challenge, a parallel event of the 16th European Congress on Digital Pathology, which aimed to predict the HER2 status in breast cancer based only on hematoxylin–eosin-stained tissue samples, thus avoiding specialized techniques. The challenge consisted of a large, annotated, whole-slide images dataset (509), specifically collected for the challenge. Models for predicting HER2 status were presented by 21 teams worldwide. The best-performing models are presented by detailing the network architectures and key parameters. Methods are compared and approaches, core methodologies, and software choices contrasted. Different evaluation metrics are discussed, as well as the performance of the presented models for each of these metrics. Potential differences in ranking that would result from different choices of evaluation metrics highlight the need for careful consideration at the time of their selection, as the results show that some metrics may misrepresent the true potential of a model to solve the problem for which it was developed. The HEROHE dataset remains publicly available to promote advances in the field of computational pathology

Molecular epidemiology of measles viruses in China, 1995–2003

This report describes the genetic characterization of 297 wild-type measles viruses that were isolated in 24 provinces of China between 1995 and 2003. Phylogenetic analysis of the N gene sequences showed that all of the isolates belonged to genotype H1 except 3 isolates, which were genotype A. The nucleotide sequence and predicted amino acid homologies of the 294-genotype H1 strains were 94.7%–100% and 93.3%–100%, respectively. The genotype H1 isolates were divided into 2 clusters, which differed by approximately 2.9% at the nucleotide level. Viruses from both clusters were distributed throughout China with no apparent geographic restriction and multiple co-circulating lineages were present in many provinces. Even though other measles genotypes have been detected in countries that border China, this report shows that genotype H1 is widely distributed throughout the country and that China has a single, endemic genotype. This important baseline data will help to monitor the progress of measles control in China

Cross-Platform Comparison of Microarray-Based Multiple-Class Prediction

High-throughput microarray technology has been widely applied in biological and medical decision-making research during the past decade. However, the diversity of platforms has made it a challenge to re-use and/or integrate datasets generated in different experiments or labs for constructing array-based diagnostic models. Using large toxicogenomics datasets generated using both Affymetrix and Agilent microarray platforms, we carried out a benchmark evaluation of cross-platform consistency in multiple-class prediction using three widely-used machine learning algorithms. After an initial assessment of model performance on different platforms, we evaluated whether predictive signature features selected in one platform could be directly used to train a model in the other platform and whether predictive models trained using data from one platform could predict datasets profiled using the other platform with comparable performance. Our results established that it is possible to successfully apply multiple-class prediction models across different commercial microarray platforms, offering a number of important benefits such as accelerating the possible translation of biomarkers identified with microarrays to clinically-validated assays. However, this investigation focuses on a technical platform comparison and is actually only the beginning of exploring cross-platform consistency. Further studies are needed to confirm the feasibility of microarray-based cross-platform prediction, especially using independent datasets